<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T04:59:09Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/9500" metadataPrefix="marc">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/9500</identifier><datestamp>2024-07-27T00:05:34Z</datestamp><setSpec>com_10259_4323</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>com_10259_9491</setSpec><setSpec>com_10259_6168</setSpec><setSpec>col_10259_4330</setSpec><setSpec>col_10259_9492</setSpec><setSpec>col_10259_6169</setSpec></header><metadata><record xmlns="http://www.loc.gov/MARC21/slim" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dcterms="http://purl.org/dc/terms/" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
<leader>00925njm 22002777a 4500</leader>
<datafield tag="042" ind1=" " ind2=" ">
<subfield code="a">dc</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Parra de la Parra, Sandra de la</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Fernández Pampín, Natalia</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Garroni, Sebastiano</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Poddighe, Matteo</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Fuente Vivas, Dalia de la</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Barros García, Rocío</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Martel Martín, Sonia</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Aparicio Martínez, Santiago</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Rumbo Lorenzo, Carlos</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Tamayo Ramos, Juan Antonio</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="260" ind1=" " ind2=" ">
<subfield code="c">2024-05</subfield>
</datafield>
<datafield tag="520" ind1=" " ind2=" ">
<subfield code="a">Despite the wide application of graphene-based materials, the information of the toxicity associated to some specific derivatives such as aminated graphene oxide is scarce. Likewise, most of these studies analyse the pristine materials, while the available data regarding the harmful effects of degraded forms is very limited. In this work, the toxicity of graphene oxide (GO), aminated graphene oxide (GO-NH2), and their respective degraded forms (dGO and dGO-NH2) obtained after being submitted to high-intensity sonication was evaluated applying in vitro assays in different models of human exposure. Viability and ROS assays were performed on A549 and HT29 cells, while their skin irritation potential was tested on a reconstructed human epidermis model. The obtained results showed that GO-NH2 and dGO-NH2 substantially decrease cell viability in the lung and gastrointestinal models, being this reduction slightly higher in the cells exposed to the degraded forms. In contrast, this parameter was not affected by GO and dGO which, conversely, showed the ability to induce higher levels of ROS than the pristine and degraded aminated forms. Furthermore, none of the materials is skin irritant. Altogether, these results provide new insights about the potential harmful effects of the selected graphene-based nanomaterials in comparison with their degraded counterparts.</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">0300-483X</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">http://hdl.handle.net/10259/9500</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">10.1016/j.tox.2024.153783</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">A549 cells</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">HT29 cells</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">3D RhE model</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Physical degradation</subfield>
</datafield>
<datafield tag="245" ind1="0" ind2="0">
<subfield code="a">Comparative toxicological analysis of two pristine carbon nanomaterials (graphene oxide and aminated graphene oxide) and their corresponding degraded forms using human in vitro models</subfield>
</datafield>
</record></metadata></record></GetRecord></OAI-PMH>